P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 2, 1998, Pages 111-120

  Tuluc, Florin ^a   Bültmann, Ralph ^a   Glänzel, Markus ^b   Frahm, August Wilhelm ^b   Starke, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Lehrst F Pharmazeutische Chemie   (Germany)

Author keywords

Acid blue 129; Ecto nucleotidase; Guinea pig taenia coli; P2 receptor antagonists; P2X receptor; P2Y receptor; Rat vas deferens; Reactive blue 2; Uniblue A

Indexed keywords

ADENOSINE 5' O (2 THIODIPHOSPHATE); ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CARBACHOL; CIBACRON BLUE F3GA; ECTO 5' NUCLEOTIDASE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; COLON TENIA; GUINEA PIG; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; GUINEA PIGS; KINETICS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NUCLEOTIDASES; RATS; RECEPTORS, PURINERGIC P2; TRIAZINES;

EID: 0031930227     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005144     Document Type: Article

References (50)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
2. 2X-purinoceptors in rat urinary bladder. Br J Pharmacol 112:1151-1159
3. Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-523
4. 2x-purinoceptors in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:684-687
5. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:74-80
6. 2x-purinoceptors in rat vas deferens. Br J Pharmacol 112:690-694
7. 2Y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase. Naunyn-Schmiedeberg's Arch Pharmacol 352:477-482
8. 2x-purinoceptors in rat vas deferens. Br J Pharmacol 113:349-354
9. Bültmann R, Driessen B, Gonçalves J, Starke K (1995) Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue. Naunyn-Schmiedeberg's Arch Pharmacol 351:555-560
10. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedebere's Arch Pharmacol 353:445-451
11. 2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates. Naunyn-Schmiedeberg's Arch Pharmacol 354:481-490
12. 2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Arch Pharmacol 354:498-504
13. Burnstock G, King BF (1996) The numbering of cloned P2 purinoceptors. Drug Dev Res 38:67-71
14. 2Y-purinoceptor. Br J Pharmacol 89:857P
15. Burton SJ, McLoughlin SB, Stead CV, Lowe CR (1988) Design and applications of biomimetic anthraquinone dyes. I. Synthesis and characterisation of terminal rine isomers of C.I. reactive blue 2. J Chromatogr 435:127-137
16. Chang K, Hanaoka K, Kumada M, Takuwa Y (1995) Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J Biol Chem 270:26152-26158
17. Choo LK (1981) The effect of reactive blue, an antagonist of ATP, on the isolated urinary bladders of guinea-pig and rat. J Pharm Pharmacol 33:248-250
18. 2Y4 receptor. Eur J Pharmacol 317:383-389
19. 2-purinoceptor-mediated depolarization of rat superior cervical ganglia by 4,4′-diisothiocyanatostilbene-2,2′-disulphonate (DIDS) and uniblue A. Br J Pharmacol 115:427-432
20. Cotton KD, Hollywood MA, Thornbury KD, McHale NG (1996) Effect of purinergic blockers on outward current in isolated smooth muscle cells of the sheep bladder. Am J Physiol 39: C969-C973
21. Den Hertog A, Pielkenrood J, Ras R, van den Akker J (1984) The contribution of calcium and potassium to the α-action of adrenaline on smooth muscle cells of the portal vein, pulmonary artery and taenia coli of the guinea-pig. Eur J Pharmacol 98:223-234
22. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedeberg's Arch Pharmacol 351:107-110
23. 2X-purinoceptors). Mol Pharmacol 48:78-183
24. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Vl. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
25. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283-335
26. Hansmann G, Bültmann R, Tuluc F, Starke K (1997) Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 356:641-652
27. Holmberg SRM, Williams AJ (1990) Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum. Circ Res 67:272-283
28. 2x-purinoceptors in the vas deferens. Br J Pharmacol 107:367-374
29. Kenakin T (1993) Pharmacologic analysis of drug-receptor interaction. Second edition. Raven Press, New York
30. 2-purinoceptor subtypes - an update. Arch Int Pharmacodyn 303:30-50
31. Kerr DIB, Krantis A (1979) A new class of ATP antagonist. Proc Austr Physiol Pharmacol Soc 10:156P
32. 2x purinoceptors in rat vas deferens. Eur J Pharmacol 263:301-309
33. 2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J Physiol 484:385-395
34. 2-purinoceptor antagonists. Br J Pharmacol 115:2P
35. 2x purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br J Pharmacol 115:177-185
36. 2-Purinoceptor heterogeneity in guinea-pig taenia coli and rabbit vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 353:R42
37. 6 glioma cells. J Pharmacol Exp Ther 269:926-931
38. McMillian MK, Soltoff SP, Cantley LC, Rudel RA, Talamo BR (1993) Two distinct cytosolic calcium responses to extracellular ATP in rat parotid acinar cells. Br J Pharmacol 108:453-461
39. Michel AD, Grahames CBA, Humphrey PPA (1996) Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedeberg's Arch Pharmacol 354:562-571
40. Molulsky HJ, Ransnas LA (1987) Fitting curves to data using non-linear regression: a practical and nonmathematical review. FASEB J 1:365-374
41. Pfeilschifter J (1990) Comparison of extracellular ATP and UTP signalling in rat renal mesangial cells. Biochem J 272:469-472
42. 2x ATP receptor ion channel with widespread distribution in the brain. J Neuroscience 15:448-455
43. 2Y purinoceptor. Eur J Pharmacol 291:281-289
44. Tuluc F, Bültmann R, Frahm AW, Starke K (1997) Blockade of P2X- and P2Y-purinoceptors by compounds related to reactive blue 2. Naunyn-Schmiedeberg's Arch Pharmacol 355:R35
45. Uneyama H, Uneyama C, Ehihara S, Akaike N (1994) Suramin and reactive blue 2 are antagonists for a newly identified purinoceptor on rat megakaryocyte. Br J Pharmacol 111:245-249
46. 2x receptor for extracellular ATP. Nature 371:516-519
47. 2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:125-132
48. Waud DR (1976) Analysis of dose-response relationships. In: Narahashi T, Bianchi CP (eds) Advances in general and cellular pharmacology, vol 1. Plenum, New York London, pp 145-178
49. 2Y3) activated preferentially by nucleoside diphosphates. Mol Pharmacol 50:258-265
50. 2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue or trypan blue. Naunyn-Schmiedeberg's Arch Pharmacol 354:491-497